Ra, Seung Won <br/><br/>
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.  [electronic resource] 

 -  Respiratory research  05 2017 
 - 109 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1465-993X 
<br/><br/><label>Standard No.: </label>10.1186/s12931-017-0594-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anti-Bacterial Agents--adverse effects<br/>Antibodies, Bacterial--blood<br/>Azithromycin--adverse effects<br/>Biomarkers--blood<br/>C-Reactive Protein--metabolism<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Helicobacter Infections--blood<br/>Helicobacter pylori--drug effects<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lung--drug effects<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Receptors, Tumor Necrosis Factor, Type II--blood<br/>Risk Factors<br/>Serologic Tests<br/>Time Factors<br/>Treatment Outcome